Newsletter

SINGAPORE: HSA ATTAINS HIGHEST LEVEL RECOGNITION FROM WHO FOR MEDICAL DEVICE REGULATORY SYSTEM – March/April 2026

SINGAPORE: HSA ATTAINS HIGHEST LEVEL RECOGNITION FROM WHO FOR MEDICAL DEVICE REGULATORY SYSTEM – March/April 2026

  • 2026-04-23 09:11:50

Singapore's Health Sciences Authority (HSA) has achieved the World Health Organization (WHO) Maturity Level 4 for medical device regulatory systems, the highest classification under WHO's global benchmarking framework. The recognition, announced on 10 March 2026 during the International Medical Device Regulators Forum (IMDRF) 29th session in Singapore, strengthens Singapore's position in global medical device regulation as a trusted reference authority for other regulators.

More
CHINA: Announcement of the National Medical Products Administration on Measures to Optimize Whole-Lifecycle Regulation to Support the Innovative Development of High-End Medical Devices (No. 63 of 2025) – JULY/AUGUST 2025

CHINA: Announcement of the National Medical Products Administration on Measures to Optimize Whole-Lifecycle Regulation to Support the Innovative Development of High-End Medical Devices (No. 63 of 2025) – JULY/AUGUST 2025

  • 2025-08-25 07:35:29

The NMPA has released new measures to foster innovation and strengthen regulation of high-end medical devices such as surgical robots, advanced imaging systems, AI medical devices, and innovative biomaterials. The policy emphasizes faster review pathways, improved standards, stronger lifecycle oversight, and enhanced international collaboration, aiming to accelerate market access and boost the global competitiveness of China's medical device industry.

More
SINGAPORE: HSA IS RECOGNIZED BY WHO AS STRINGENT REGULATORY AUTHORITY (SRA) FOR CLASS C AND D IN VITRO DIAGNOSTIC MEDICAL DEVICES (IVD) - JULY/AUGUST 2023

SINGAPORE: HSA IS RECOGNIZED BY WHO AS STRINGENT REGULATORY AUTHORITY (SRA) FOR CLASS C AND D IN VITRO DIAGNOSTIC MEDICAL DEVICES (IVD) - JULY/AUGUST 2023

  • 2023-07-21 02:32:25

Singapore's Health Science Authority (HSA) is pleased to announce their status as a recognized Stringent Regulatory Authority (SRA) for Class C and D IVD by WHO. The SRA status means high-risk IVD products registered with HSA might obtain faster evaluation through WHO prequalification assessment, enabling manufacturers accelerated access to global markets.

More
Whole New Qualtech Website

Whole New Qualtech Website

  • 2020-02-15 09:11:10

Friendly interface and specific information could make you much more easily to know Qualtech and latest regulatory around the Asian countries.

More
Whole new services in Malaysia!

Whole new services in Malaysia!

  • 2020-02-15 08:22:55

In order to provide customers with more complete medical device regulatory services in the Asian region, Qualtech establishs service presence in Malaysia.

More